We are live on ! Find out more
LKIM

Lawson Kroeker Investment Management Portfolio holdings

AUM $361M
1-Year Est. Return 22.26%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+22.26%
3 Year Est. Return
+64.49%
5 Year Est. Return
+92.04%
10 Year Est. Return
+404.21%
AUM
$531M
AUM Growth
-$17.8M
Cap. Flow
-$11.3M
Cap. Flow %
-2.13%
Top 10 Hldgs %
41.7%
Holding
91
New
3
Increased
10
Reduced
61
Closed

Top Sells

Rank Stock Value
1
TPL icon
Texas Pacific Land
TPL
+$4.17M
2
AFL icon
Aflac
AFL
+$2.81M
3
WFC icon
Wells Fargo
WFC
+$1.72M
4
WAT icon
Waters Corp
WAT
+$1.24M
5
LKQ icon
LKQ Corp
LKQ
+$1.16M

Sector Composition

Rank Sector Weight
1 Financials 26.18%
2 Healthcare 14.93%
3 Energy 14.35%
4 Consumer Discretionary 10.63%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1
Texas Pacific Land
TPL
$25.1B
$51.2M 9.64%
138,927
-10,194
-7% -$4.17M
BRK.B icon
2
Berkshire Hathaway Class B
BRK.B
$1.11T
$33.7M 6.35%
74,411
-311
-0.4% -$144K
AJG icon
3
Arthur J. Gallagher & Co
AJG
$65.4B
$20.2M 3.8%
71,015
-2,043
-3% -$595K
MSFT icon
4
Microsoft
MSFT
$3.74T
$18.7M 3.52%
44,408
-567
-1% -$242K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.21T
$18.7M 3.52%
98,104
-1,955
-2% -$345K
AZO icon
6
AutoZone
AZO
$50B
$18.4M 3.46%
5,735
-32
-0.6% -$101K
CPRT icon
7
Copart
CPRT
$27.4B
$16M 3.02%
279,546
-4,587
-2% -$261K
HCA icon
8
HCA Healthcare
HCA
$89.1B
$16M 3.02%
53,429
+455
+0.9% +$159K
BRK.A icon
9
Berkshire Hathaway Class A
BRK.A
$1.11T
$15M 2.82%
22
-1
-4% -$693K
FITB
10
Fifth Third Bancorp
FITB
$52.3B
$13.5M 2.54%
319,430
-23,971
-7% -$1.08M
AFL icon
11
Aflac
AFL
$61B
$13.4M 2.52%
129,545
-25,786
-17% -$2.81M
PSX icon
12
Phillips 66
PSX
$89.1B
$11.9M 2.24%
104,590
-1,503
-1% -$191K
ELV icon
13
Elevance Health
ELV
$84.6B
$11.8M 2.23%
32,088
+4,372
+16% +$1.83M
ABG icon
14
Asbury Automotive
ABG
$3.78B
$11.3M 2.12%
46,359
-472
-1% -$116K
BN icon
15
Brookfield
BN
$110B
$11.1M 2.08%
289,041
-17,876
-6% -$673K
NNI icon
16
Nelnet
NNI
$4.51B
$11M 2.07%
102,964
+187
+0.2% +$20.7K
DIS icon
17
Walt Disney
DIS
$178B
$10.8M 2.03%
96,995
-4,048
-4% -$425K
CRL icon
18
Charles River Laboratories
CRL
$13.4B
$10.2M 1.91%
55,037
-1,498
-3% -$289K
LECO icon
19
Lincoln Electric
LECO
$15.5B
$9.93M 1.87%
52,942
-760
-1% -$153K
ENOV icon
20
Enovis
ENOV
$1.42B
$9.45M 1.78%
215,440
-2,233
-1% -$98.1K
HSY icon
21
Hershey
HSY
$36.6B
$9.21M 1.74%
54,412
+4,674
+9% +$838K
TMO icon
22
Thermo Fisher Scientific
TMO
$223B
$8.2M 1.54%
15,755
-421
-3% -$231K
JNJ icon
23
Johnson & Johnson
JNJ
$626B
$7.58M 1.43%
52,397
-1,029
-2% -$159K
CIVI
24
DELISTED
Civitas Resources
CIVI
$7.49M 1.41%
163,263
-13,195
-7% -$657K
CFR icon
25
Cullen/Frost Bankers
CFR
$10.4B
$7.18M 1.35%
53,463
-874
-2% -$115K

Similar funds

Lawson Kroeker Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Lawson Kroeker Investment Management held 91 positions worth $531M, down 3.2% from $549M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.3%. Lawson Kroeker Investment Management opened 3 new positions and made no exits, leaving the 91-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Energy.

  • Lawson Kroeker Investment Management's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 5,083 shares worth $2.98M.
  • Lawson Kroeker Investment Management added most to Sky Harbour Group in Q4 2024, an estimated $2.41M increase.
  • Lawson Kroeker Investment Management's biggest Q4 2024 reduction was Texas Pacific Land, cutting an estimated $4.17M.
  • Lawson Kroeker Investment Management's ten largest holdings make up 42% of its $531M portfolio in Q4 2024.
  • Lawson Kroeker Investment Management opened 3 new positions and closed 0 in Q4 2024.
  • Lawson Kroeker Investment Management's portfolio value fell 3.2% quarter-over-quarter to $531M.

Based on Lawson Kroeker Investment Management's 13F filing for Q4 2024, filed 23 Jan 2025.